PR90689

TAIPEI, July 19, 2021 /PRNewswire=KYODO JBN/ --

According to the World Report on Vision published in 2020 by World Health

Organization (WHO), the incidence of most eye diseases and visual impairments

varies by age, area of residence, and income level. As people age, the risk of

developing cataracts, presbyopia, glaucoma and age-related macular degeneration

increases, and in high-income countries, the prevalence of eye diseases is

found higher than in middle- and low-income countries. The Report indicates

that high-income countries of the Asia-Pacific region have the highest overall

prevalence of myopia (53.4%). A recent survey has shown that people use

electronic devices for an average of 10.7 hours a day and that 32% of teenagers

and young adults watch videos online for more than 3 hours every day in these

countries. Studies have proven staring at screens closely over long periods of

time can cause eye conditions such as ciliary muscle strain, eyes strain,

ametropia, dry eyes, macular degeneration, cataracts, and glaucoma. However,

surprisingly, with the highest proportion of elderly population in the world

and world-leading technology development for electronic devices, Japan has

fewer eye disease patients than South Korea, Singapore and other high-income

countries of the Asia-Pacific region. TCI JAPAN, with years of experience in

product development, has successfully developed the Ultra-High-Concentration

Lutein Drops, which is expected to bring a brand new eye care experience to

consumers around the world.

Japanese people have attached importance to vision care since childhood. In

addition to good living habits, Japanese people also take dietary supplements

for eye health. Among the wide range of eye care supplements on the market in

Japan, lutein products has always been no.1 in sales. But, since lutein is

fat-soluble and easily oxidized, it must be encapsulated in soft gels, a dosage

form far from favorable for the elderly or children. Food scientists have long

been trying to develop lutein supplements in new dosage forms suitable for

people of all ages and exploring ways to ensure lutein can be truly and

efficiently absorbed and utitlized by the human body.

TCI JAPAN, using its patented Double Nutri™ technology, encapsulates lutein

with micron-sized liposomes, one-ninth the size of human red blood cells, to

completely inhibit the deterioration of the fat-soluble and easily oxidized

active ingredient and optimize the bioavailability. In the past, commercially

available nutritional supplements combining components in water and oil phases

often troubled consumers with problems such as separation of oil and water

components, suspended substances, and odor. Now with the patented Double Nutri™

technology, these problems are completely solved.

Moreover, TCI JAPAN is equipped with the proprietary Synergene® technology

using which an exclusive formula platform has been built with a database of

hundreds of active compound combinations to ensure ingredients are incorporated

to provide best health effects and create high-potency formulas. The Double

Nutri™ technology and Synergene® technology have been patented in Japan and

awarded with a Special Japanese Jury Prize at IITEXPO LONDON, respectively, in

2020. The efficient absorption of active ingredients is the key to making

health foods truly "join and delight consumer's life". TCI JAPAN, with its

strength in scientific research and advantages of R&D technology, has

successfully developed the easy-to-take lutein supplement with higher

concentration and bioavailability, enabling people of all ages to take care of

their eyes easily.

Contact Information:

TCI Academy COO

Aaron Chen

Mobile: +886-972-862705

Email: Aaron.Chen@tci-bio.com

SOURCE  TCI

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=396431

   Caption: Japan has surpassed itself again with the development of

ultra-high-concentration lutein